Lipid signaling in the atherogenesis context

Area of Science:

• Cardiovascular Biology
• Immunology
• Metabolic Regulation

Background:

• Macrophages in arterial walls normally regulate cholesterol via reverse transfer.
• Lipid sensors (LXR, PPAR, INSIG, SCAP, SREBP) control macrophage cholesterol homeostasis and inflammation.
• Modified LDL accumulation and TLR4 activation disrupt macrophage function, promoting foam cell formation and atherosclerosis.

Purpose of the Study:

• To investigate the role of lipid sensors in macrophage cholesterol metabolism and foam cell formation.
• To explore therapeutic strategies targeting lipid signaling pathways for atherosclerosis treatment.

Main Methods:

• Analysis of macrophage cholesterol homeostasis mechanisms.
• Investigation of lipid sensor interactions (LXR, PPAR, TLR4) with modified LDL.
• Evaluation of LXR and PPARgamma agonists for therapeutic potential.

Main Results:

• Macrophage dysfunction, driven by modified LDL and TLR4, leads to foam cell transformation.
• Activation of LXR and PPAR inhibits inflammation and promotes cholesterol efflux.
• LXR and PPARgamma agonists show promise in re-establishing cholesterol homeostasis.

Conclusions:

• Targeting macrophage lipid metabolism is crucial for treating atherosclerosis.
• LXR and PPAR agonists represent a potential therapeutic avenue, but ligand design needs optimization to minimize side effects.